Company Filing History:
Years Active: 1998-2004
Title: Innovations and Contributions of Inventor Jean-Michel Lacroix
Introduction
Jean-Michel Lacroix, located in Etobicoke, Canada, is a notable inventor recognized for his significant contributions to the field of nucleic acid analysis. With a portfolio boasting nine patents, Lacroix has developed innovative methodologies that enhance the understanding of genetic materials, particularly in the context of infectious diseases.
Latest Patents
Among his latest patents is a groundbreaking method and kit for the quantitation and nucleic acid sequencing of nucleic acid analytes in a sample. This invention allows for both quantitative and qualitative analysis of nucleic acid analytes, crucial for understanding their presence in biological samples. By preparing a reaction mixture that includes a known quantity of an internal quantitation standard, this method enables the amplification of nucleic acids, facilitating the distinction between sample fragments and control fragments. The quantification process relies on analyzing the relative amounts of these fragments, thereby allowing for an assessment of the nucleic acid analyte's sequence and quantity.
Another significant patent developed by Lacroix focuses on the evaluation of HIV mutations. This method involves using a nested set of sequencing primers to maximize the potential for sequencing specific genetic samples obtained from HIV-infected individuals. The reagents required for these tests are conveniently packaged as a kit, simplifying the testing process for researchers and healthcare providers.
Career Highlights
Throughout his career, Jean-Michel Lacroix has worked with prominent companies such as Visible Genetics Inc. and Bayer Healthcare LLC. His involvement with these organizations has significantly contributed to the advancement of genetic testing technologies, paving the way for improved diagnostic methods and therapeutic strategies.
Collaborations
Lacroix's innovations have also been shaped by collaborations with talented professionals, including coworkers James M. Dunn and James Leushner. These partnerships have fostered a creative environment where groundbreaking ideas can flourish, ultimately leading to the successful development of valuable patents.
Conclusion
Jean-Michel Lacroix remains an influential figure in the field of genetics, with his nine patents reflecting his commitment to innovation and scientific progress. His latest work in nucleic acid quantitation and HIV mutation evaluation demonstrates his dedication to enhancing our understanding of complex biological systems, ultimately contributing to advancements in healthcare and research.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.